Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathilde Leclercq
David Saadoun

Ophthalmology

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Ophthalmology|November 18, 2021
Anti-Tumor Necrosis Factor α versus Tocilizumab in the Treatment of Refractory Uveitic Macular Edema: A Multicenter Study from the French Uveitis NetworkMathilde Leclercq, Anaïs Andrillon, Georgina Maalouf, et al.
Ophthalmology|June 8, 2025
Corticosteroids with or without Conventional Disease-Modifying Antirheumatic Drug as First-Line Therapy in Nonanterior Sarcoidosis UveitisRobin Jacquot, Pascal Sève, Guillaume Mulier, et al.
Ophthalmology|May 21, 2025
Comparative effectiveness of intravenous versus subcutaneous tocilizumab for refractory uveitis: a retrospective analysisMathilde Leclercq, Robin Jacquot, Camille Charbonnier, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Ophthalmology|November 18, 2021
Anti-Tumor Necrosis Factor α versus Tocilizumab in the Treatment of Refractory Uveitic Macular Edema: A Multicenter Study from the French Uveitis NetworkMathilde Leclercq, Anaïs Andrillon, Georgina Maalouf, et al.
Ophthalmology|June 8, 2025
Corticosteroids with or without Conventional Disease-Modifying Antirheumatic Drug as First-Line Therapy in Nonanterior Sarcoidosis UveitisRobin Jacquot, Pascal Sève, Guillaume Mulier, et al.
Ophthalmology|May 21, 2025
Comparative effectiveness of intravenous versus subcutaneous tocilizumab for refractory uveitis: a retrospective analysisMathilde Leclercq, Robin Jacquot, Camille Charbonnier, et al.
Pageof 1